Association between women’s baseline characteristics and previous pap testing and knowledge and acceptability of Pap screening.

1Compares women who reported Pap smear screening prior to enrollment in the study (n = 57) to women with no previous screening (n = 347).2Compares women who had heard of HPV (n = 75) to the women who had never heard of HPV (n = 328).3Compares women who know (n = 74) and do not know (n = 335) that Pap smear screening is used to prevent invasive cervical cancer.4Compares women who gave Pap smear screening the highest rating (100 on scale from 0 to 100) for acceptability (n = 193) to those who gave less than the highest (5History of smoking: ≥1 cig/day for ≥6 consecutive months.6Hormonal contraception includes injection, oral and implant-based contraceptive.Abbreviations: OR (unadjusted odds ratio); CI (confidence interval); N (number); % (percentage); HIV (human immunodeficiency virus); HPV (human papillomavirus); IQR (interquartile range); ICC (invasive cervical cancer); IN (infinity, could not reliably estimate because of small numbers).Missing data: Hormonal contraception (n = 1); Median age at sexual debut (n = 1); Lifetime number of partners (n = 1); Condom use at last sex (n = 51); abnormal cytology at baseline (n = 25).